Science Arts, Inc. (TYO:4412)
1,125.00
-16.00 (-1.40%)
Jun 18, 2026, 2:40 PM JST
Science Arts Balance Sheet
Financials in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cash & Equivalents | 1,563 | 1,579 | 562 | 504 | 663 | 260 |
Cash & Short-Term Investments | 1,563 | 1,579 | 562 | 504 | 663 | 260 |
Cash Growth | 8.02% | 180.96% | 11.51% | -23.98% | 155.00% | -30.29% |
Receivables | 168 | 151 | 101 | 66 | 35 | 46 |
Inventory | 161 | 60 | 65 | 76 | 28 | 13 |
Prepaid Expenses | - | 43 | 23 | 17 | 11 | 3 |
Other Current Assets | 53 | 1 | 1 | 4 | 2 | 1 |
Total Current Assets | 1,945 | 1,834 | 752 | 667 | 739 | 323 |
Property, Plant & Equipment | 83 | 109 | 108 | 112 | 30 | 12 |
Long-Term Investments | 251 | 100 | 92 | 113 | 31 | 15 |
Long-Term Deferred Tax Assets | - | 33 | - | - | - | - |
Other Long-Term Assets | 1 | 1 | 1 | 2 | 1 | 1 |
Total Assets | 2,280 | 2,077 | 953 | 894 | 801 | 351 |
Accounts Payable | 99 | 40 | 8 | 16 | 14 | 25 |
Accrued Expenses | 7 | 39 | 30 | 41 | 19 | 14 |
Current Portion of Long-Term Debt | 35 | 40 | 48 | - | - | - |
Current Income Taxes Payable | 23 | 111 | 57 | 65 | 35 | 8 |
Current Unearned Revenue | 432 | 370 | 222 | 180 | 135 | 63 |
Other Current Liabilities | 114 | 10 | 8 | 13 | 3 | 2 |
Total Current Liabilities | 710 | 610 | 373 | 315 | 206 | 112 |
Long-Term Debt | 20 | 27 | 40 | - | - | - |
Long-Term Deferred Tax Liabilities | - | - | 6 | 9 | - | - |
Other Long-Term Liabilities | 48 | 47 | 58 | 62 | 25 | 6 |
Total Liabilities | 778 | 684 | 477 | 386 | 231 | 118 |
Common Stock | 459 | 450 | 52 | 52 | 50 | 50 |
Additional Paid-In Capital | 1,200 | 1,188 | 781 | 781 | 765 | 450 |
Retained Earnings | -154 | -241 | -353 | -321 | -240 | -249 |
Treasury Stock | -3 | -3 | -3 | -3 | -4 | -17 |
Comprehensive Income & Other | - | -1 | -1 | -1 | -1 | -1 |
Shareholders' Equity | 1,502 | 1,393 | 476 | 508 | 570 | 233 |
Total Liabilities & Equity | 2,280 | 2,077 | 953 | 894 | 801 | 351 |
Total Debt | 55 | 67 | 88 | - | - | - |
Net Cash (Debt) | 1,508 | 1,512 | 474 | 504 | 663 | 260 |
Net Cash Growth | 10.07% | 218.99% | -5.95% | -23.98% | 155.00% | -15.86% |
Net Cash Per Share | 184.73 | 192.96 | 72.00 | 76.64 | 197.43 | 85.62 |
Filing Date Shares Outstanding | 8.11 | 8.1 | 6.58 | 6.58 | 3.28 | 3.04 |
Total Common Shares Outstanding | 8.11 | 8.1 | 6.58 | 6.58 | 3.28 | 3.04 |
Working Capital | 1,235 | 1,224 | 379 | 352 | 533 | 211 |
Book Value Per Share | 185.28 | 171.99 | 72.30 | 77.17 | 173.72 | 76.55 |
Tangible Book Value | 1,502 | 1,393 | 476 | 508 | 570 | 233 |
Tangible Book Value Per Share | 185.28 | 171.99 | 72.30 | 77.17 | 173.72 | 76.55 |